戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 , included improved contractile function and left ventricular remodeling.
2 ardiac functional recovery and prevention of left ventricular remodeling.
3  studies support a key role for cytokines in left ventricular remodeling.
4 t role in the development and progression of left ventricular remodeling.
5  to provoke left ventricular dysfunction and left ventricular remodeling.
6 duce morbidity and mortality associated with left ventricular remodeling.
7 cies may participate in mechanically induced left ventricular remodeling.
8 improve understanding of the role of MMPs in left ventricular remodeling.
9 t noninfarcted regions, as well as attenuate left ventricular remodeling.
10 me constant of relaxation or any variable of left ventricular remodeling.
11 me that regulates post-myocardial infarction left ventricular remodeling.
12 stolic and diastolic function, and decreased left ventricular remodeling.
13 art failure-related urgent care, and adverse left ventricular remodeling.
14 mprove clinical outcomes and prevent adverse left ventricular remodeling.
15 ocardial injury and its predictive value for left ventricular remodeling.
16 and exerted a sustained beneficial effect on left ventricular remodeling.
17 MAD-3 largely prevented fibrosis and limited left ventricular remodeling.
18 ment option for patients with postinfarction left ventricular remodeling.
19 after myocardial infarction (MI) accelerates left ventricular remodeling.
20 ic myocardium and has been linked to adverse left ventricular remodeling.
21 ted infarct inflammation, and curbed post-MI left ventricular remodeling.
22  cardiac pathologies, including post-infarct left ventricular remodeling.
23 in murine infarcts and consequently enhances left ventricular remodeling.
24 escued the angiogenic defect and ameliorated left ventricular remodeling.
25 ounding tissue, which often leads to adverse left ventricular remodeling.
26 triuretic peptide (BNP), and fully prevented left-ventricular remodeling.
27 on of 59.3+/-7.9%, with prevalent concentric left ventricular remodeling (34%) and hypertrophy (43%),
28 ogenesis and survival of cardiac myocyte and left ventricular remodeling after AMI is unknown.
29               In concert with a reduction in left ventricular remodeling after anterior infarction, a
30                                              Left ventricular remodeling after infarction is accompan
31 d regions may be an important determinant of left ventricular remodeling after infarction.
32 ay provide a novel means to favorably modify left ventricular remodeling after MI.
33 trix metalloproteinases (MMPs) contribute to left ventricular remodeling after myocardial infarction
34  matrix metalloproteinases (MMPs) attenuates left ventricular remodeling after myocardial infarction
35  in plasma RNA from patients with or without left ventricular remodeling after myocardial infarction.
36 amine BP, the incidence of hypertension, and left ventricular remodeling among collegiate ASF athlete
37  species production and again observed worse left ventricular remodeling and a lower ejection fractio
38 omoted their angiogenic ability, attenuating left ventricular remodeling and cardiac fibrosis.
39                                              Left ventricular remodeling and cardiac function were im
40  the post-infarction progression of negative left ventricular remodeling and decline in cardiac funct
41 yocardium is directly cardiotoxic and causes left ventricular remodeling and dilated cardiomyopathy.
42            The beneficial effects of CPCs on left ventricular remodeling and dysfunction are sustaine
43 old (IK-5001), to prevent or reverse adverse left ventricular remodeling and dysfunction in patients
44  hypertension, and renal insufficiency drive left ventricular remodeling and dysfunction through syst
45 e MSC(LacZ) group; MSC(HO-1) also attenuated left ventricular remodeling and enhanced the functional
46 greatest negative effect on infarct size and left ventricular remodeling and function, as well as a s
47 a alone or in combination with parameters of left ventricular remodeling and function, yielded an imp
48 s provide evidence for beneficial effects on left ventricular remodeling and functional capacity.
49                                              Left ventricular remodeling and global and regional func
50 acellular biomaterials hold promise to limit left ventricular remodeling and heart failure precipitat
51 te or greater MR was associated with adverse left ventricular remodeling and increased likelihood of
52 tral valve repair is associated with adverse left ventricular remodeling and late death.
53 vation of inflammation in the heart provokes left ventricular remodeling and left ventricular dysfunc
54            Women demonstrate more concentric left ventricular remodeling and less ventricular dilatat
55 ling pathways that may contribute to adverse left ventricular remodeling and mitochondrial dysfunctio
56 PMA exerted a long-term beneficial effect on left ventricular remodeling and more effectively restore
57 e found to be most effective in ameliorating left ventricular remodeling and preserving function.
58 dium in the risk region, along with improved left ventricular remodeling and regional and global left
59 onary artery systolic pressure but mainly on left ventricular remodeling and septal function.
60 therapy did not improve clinical outcomes or left ventricular remodeling and was associated with pote
61 post-PPCI, and it is associated with adverse left ventricular remodeling and worse clinical outcomes.
62 tective response and inhibiting pathological left ventricular remodeling and, therefore, may be a use
63  is principally caused by global or regional left ventricular remodeling and/or severe left atrial di
64 ophy, left ventricular dilation, and adverse left ventricular remodeling, and a significant decrease
65                                   Apoptosis, left ventricular remodeling, and cardiac function were t
66 ric analysis revealed maximal attenuation of left ventricular remodeling, and echocardiography showed
67                    Diastolic dysfunction and left ventricular remodeling are most marked in severe an
68                                              Left ventricular remodeling, as commonly measured by lef
69 ospitalization for heart failure, or adverse left ventricular remodeling at 1 year.
70 ose with placebo and did not prevent adverse left ventricular remodeling at 1 year.
71 systolic volume index (LVESVI), a measure of left ventricular remodeling, at 1 year.
72  MCP-1 results in attenuated post-infarction left ventricular remodeling, at the expense of a prolong
73 MO, iron deposition, infarct resorption, and left ventricular remodeling between day 7 (acute) and we
74   Ethnicity is an established determinant of left ventricular remodeling; black athletes (BAs) exhibi
75 jured myocardium plays a significant role in left ventricular remodeling, but not infarct size.
76 cardiomyocytes, MCP-1-/- mice had attenuated left ventricular remodeling, but similar infarct size wh
77               These findings support adverse left ventricular remodeling by prenatal T excess.
78 ves hemodynamic profiles and induces reverse left ventricular remodeling by reducing left ventricular
79 ped larger infarct scars and more pronounced left ventricular remodeling compared with wild-type mice
80         Hypertension (HTN) causes concentric left ventricular remodeling, defined as an increased rel
81 ve favorable cardiac effects associated with left ventricular remodeling early after myocardial infar
82                    MMP inhibition attenuates left ventricular remodeling even when the dominant colla
83 h lack of functional recovery and adverse LV left ventricular remodeling extending to remote myocardi
84             At 6 weeks after aortic banding, left ventricular remodeling, extent of hypertrophy, and
85 ects with high-output HF displayed eccentric left ventricular remodeling, greater natriuretic peptide
86 L [2380-3006 mL]; P<0.0001), more concentric left ventricular remodeling, greater right ventricular d
87 .72]; P=0.004) and the likelihood of adverse left ventricular remodeling (&gt;20% change in left ventric
88                                Parameters of left ventricular remodeling have been quantified as risk
89                                   Changes in left ventricular remodeling have not been adequately eva
90 icantly affect postinfarct myocardial and LV left ventricular remodeling; hemorrhagic infarcts behave
91 of metoprolol) attenuates the progression of left ventricular remodeling in a rat model of myocardial
92          Beta-blocker therapy can ameliorate left ventricular remodeling in asymptomatic patients wit
93 ted whether beta-blocker therapy ameliorates left ventricular remodeling in asymptomatic patients wit
94  matrix metalloproteinases (MMPs) attenuates left ventricular remodeling in experimental MI.
95 ible interaction of ASA and beta-blockers on left ventricular remodeling in patients with heart failu
96 d c-kit(+) cardiac stem cells (CSCs) improve left ventricular remodeling in porcine models and clinic
97 roves functional status, and induces reverse left ventricular remodeling in selected populations with
98 roves functional status, and induces reverse left ventricular remodeling in selected populations with
99  insights into the pathophysiology of MI and left ventricular remodeling in small-animal models.
100 dial injury, and it is a strong predictor of left ventricular remodeling in ST-segment-elevation myoc
101 ght reduce mortality, morbidity, and adverse left ventricular remodeling in such patients.
102 tory burden, infarct resorption, and adverse left ventricular remodeling in the chronic phase of MI i
103 tudy was to describe the long-term course of left ventricular remodeling induced by cardiac resynchro
104                              Disease-related left ventricular remodeling is a complex process involvi
105                                              Left ventricular remodeling is a major cause of progress
106                                              Left ventricular remodeling is a precursor of LV dysfunc
107                                              Left ventricular remodeling is an important sequela of m
108 itral regurgitation and enhanced reversal of left ventricular remodeling is possible when subvalvular
109                                              Left ventricular remodeling is the principal cause of pr
110 ease, such as hypertrophy and other types of left ventricular remodeling, ischemia/reperfusion injury
111 vided important insights into postinfarction left ventricular remodeling, it has not been possible to
112 onic mitral regurgitation results in adverse left ventricular remodeling, its effect on the mitral va
113                               Postinfarction left ventricular remodeling (LVR) is associated with red
114           The underlying mechanisms by which left ventricular remodeling (LVR) leads to congestive he
115 ion in pigs, demonstrating either successful left ventricular remodeling (LVR, n = 8) or congestive h
116 h better systolic valve performance, similar left ventricular remodeling, more paravalvular regurgita
117 ids was associated with reduction of adverse left ventricular remodeling, noninfarct myocardial fibro
118     HIIT was not superior to MCT in changing left ventricular remodeling or aerobic capacity, and its
119 etween mutation carriers and noncarriers (no left ventricular remodeling or fibrosis, normal left ven
120 rous scar formation (chi2 = 10.0, P<.01) and left ventricular remodeling (P<.05).
121 s of insulin-like growth factor I (IGF-I) on left ventricular remodeling, partly through its antiapop
122                                       We use left ventricular remodeling postmyocardial infarction as
123  to test the hypothesis that the severity of left ventricular remodeling predicts the response to tre
124  contractile parameters were associated with left ventricular remodeling, recapitulation of fetal gen
125 n, hemodynamic severity of stenosis, adverse left ventricular remodeling, reduced left ventricular lo
126 r biomaterial treatment of MI and subsequent left ventricular remodeling remain the same, namely, lef
127                                              Left ventricular remodeling secondary to acute myocardia
128                                              Left ventricular remodeling seems to be an important fac
129 ever, we found only a modest acceleration of left ventricular remodeling, suggesting that, in individ
130  viability studies are predictive of reverse left-ventricular remodeling, symptom improvement, and pa
131 ve beta-blockade was associated with adverse left ventricular remodeling, systolic dysfunction, and a
132 ral valve in the setting of advanced adverse left ventricular remodeling that alters the alignment ch
133 t at 12 months of age the T2DN(mtFHH) showed left ventricular remodeling that was verified by histolo
134 e biological changes responsible for adverse left ventricular remodeling, the relationship between in
135 lines in LVEF; however, trastuzumab-mediated left ventricular remodeling-the primary outcome-was not
136                   During the early phases of left ventricular remodeling, there was a significant inc
137                                      Adverse left ventricular remodeling was defined as an increase o
138 n in another 6 sheep (tethered plus MI), and left ventricular remodeling was limited by external cons
139 ar weights in proportion to body growth, but left ventricular remodeling was minor, and a decrease in
140 tudy of asymptomatic individuals, concentric left ventricular remodeling was related to decreased reg
141           To relate inflammatory activity to left ventricular remodeling, we used a combination of no
142  improved cardiac contractility and reversed left ventricular remodeling, which was accompanied by a
143  descending artery occlusion in swine caused left ventricular remodeling with a decrease of ejection
144 reas nontransgenic mice exhibited concentric left ventricular remodeling with maintained ejection per

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top